TOWERS WATSON & CO As previously announced, the Towers Watson Special Meeting of Stockholders has been adjourned until , in order to allow stockholders additional time to evaluate the amended merger agreement. stockholders of record as of the close of business on will be entitled to vote at the Towers Watson Special Meeting.
The Towers Watson Board remains confident the /Willis merger is in the best interest of Towers Watson's stockholders and unanimously recommends that stockholders vote 'FOR' the approval and adoption of the amended Merger Agreement and related proposals at the Special Meeting. Stockholders that have questions about how to vote their shares, or need additional assistance, should contact at (800) 322-2885 / (212) 929-5500.
About
is a leading global professional services company that helps organizations improve performance through effective people, risk and financial management. With 16,000 associates around the world, the company offers consulting, technology and solutions in the areas of benefits, talent management, rewards, and risk and capital management. Learn more at towerswatson.com.
Where You Can Find Additional Information
In connection with the proposed merger of and , filed a registration statement on Form S-4 with the (the 'Commission') that contains a joint proxy statement/prospectus and other relevant documents concerning the proposed transaction. The registration statement on Form S-4 was declared effective by the Commission on . Each of mailed the joint proxy statement/prospectus to its respective stockholders on or around . YOU ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS AND THE OTHER RELEVANT DOCUMENTS THAT HAVE BEEN OR WILL BE FILED WITH THE COMMISSION AS THEY BECOME AVAILABLE BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT TOWERS WATSON, WILLIS GROUP AND THE PROPOSED TRANSACTION. You may obtain the joint proxy statement/prospectus and the other documents filed with the Commission free of charge at the Commission's website, www.sec.gov. In addition, you may obtain free copies of the joint proxy statement/prospectus and the other documents filed by and with the Commission by requesting them in writing from , , 22203, Attention: Investor Relations, or by telephone at (703) 258-8000, or from , , , 7th Floor, 10281-1003, Attention: Investor Relations, or by telephone at (212) 915-8084.
Forward-Looking Statements
This document contains 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements and other forward-looking statements in this document by words such as 'may', 'will', 'would', 'expect', 'anticipate', 'believe', 'estimate', 'plan', 'intend', 'continue', or similar words, expressions or the negative of such terms or other comparable terminology. These statements include, but are not limited to, the benefits of the business combination transaction involving and , including the combined company's future financial and operating results, plans, objectives, expectations and intentions and other statements that are not historical facts. Such statements are based upon the current beliefs and expectations of Towers Watson's and Willis Group's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements.
The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: the ability to obtain governmental approvals of the transaction on the proposed terms and schedule; the failure of stockholders and shareholders to approve the transaction; the failure of the transaction to close for any reason; the risk that the businesses will not be integrated successfully; the risk that anticipated cost savings and any other synergies from the transaction may not be fully realized or may take longer to realize than expected; the potential impact of the announcement or consummation of the proposed transaction on relationships, including with employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; significant competition; compliance with extensive government regulation; the combined company's ability to make acquisitions and its ability to integrate or manage such acquired businesses. Additional risks and factors are identified under 'Risk Factors' in Towers Watson's Annual Report on Form 10-K filed on , which is on file with the Commission, and under 'Risk Factors' in the joint proxy statement/prospectus.
You should not rely upon forward-looking statements as predictions of future events because these statements are based on assumptions that may not come true and are speculative by their nature. Neither or undertakes an obligation to update any of the forward-looking information included in this document, whether as a result of new information, future events, changed expectations or otherwise.
Based on implied consideration at close of of (2.649 shares of WSH at + cash) and at close of (the day prior to adjournment) of (2.649 shares of WSH at + cash).
View source version on businesswire.com:http://www.businesswire.com/news/home/20151130005677/en/
Source:
Investors
Towers Watson
Aida Sukys, +1 703-258-8033
aida.sukys@towerswatson.com
or
Media
Sard Verbinnen & Co
Michael Henson/Conrad Harrington
+44 (0) 20 3178 8914
or
Bryan Locke/Jenny Gore
+1 312-895-4700
Towers Watson Co. issued this content on 2015-11-30 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 2015-12-24 14:23:47 UTC
Original Document: http://phx.corporate-ir.net/phoenix.zhtml?c=123884&p=irol-newsArticle&ID=2118693
